Stuttgart, 8 March 2024 / The high-tech company Q.ANT and Fraunhofer IPA today signed an agreement to establish the Competence Centre Human-Machine-Interface. The aim of the cooperation is to detect finest nerve signals from muscle activity and interpret the resulting information in order to control machines and devices. This could make it possible to intuitively control hand prostheses in the future.
Q.ANT plays a leading role in the field of magnetic field sensors based on quantum technology. “The sensor from Q.ANT enables the fine sensitivities that we need for reading biosignals,” says Urs Schneider, Head of Biomechatronics Research at Fraunhofer IPA.
The competence centre is based in Stuttgart and brings together around 15 experts from research and industry.
“We want to control prosthetic hands, just like healthy limbs, using neural impulses. Fraunhofer IPA brings proven expertise in this field of biomechatronics to our strategic partnership. This can be used to develop completely new applications in medical technology. We are therefore among the pioneers in this promising field of application for quantum sensor technology and are redefining the human-machine-interface,” says Michael Förtsch, CEO of Q.ANT, which specialises in photonic quantum technologies for sensing and computing.
Both cooperation partners bring many years of experience to the collaboration: Q.ANT has been developing a magnetic field sensor based on quantum technology for five years. It is characterised by its combination of sensitivity, size and operation at room temperature. Fraunhofer IPA can draw on more than 15 years of expertise in biomechatronics and biosignal processing. The IPA specialists will characterise biosignals in order to program the corresponding algorithms that convert the sensor data into control commands for the prosthesis. The Fraunhofer Institute will also carry out the corresponding series of tests with patients, the results of which will be incorporated into the development of the prosthesis prototypes.
Caption: Urs Schneider from Fraunhofer IPA and Michael Foertsch from Q.ANT have set themselves ambitious goals for the development of innovative prosthesis control systems with this partnership.
About Q.ANT
Q.ANT is a high-tech start-up that is developing and industrialising photonic quantum technologies, thereby pushing the boundaries to new fields of application and processes. The company is working on technologies for data generation and data processing by developing quantum sensors and photonic processors. With its four product lines Photonic Computing, Particle Metrology, Atomic Gyroscopes and Magnetic Sensing, Q.ANT is a partner for a wide variety of industries and fields of application, ranging from medical technology and autonomous driving to aerospace, mechanical engineering and process technology. Q.ANT employs around 100 people at its Stuttgart site.
About Fraunhofer IPA
The Fraunhofer Institute for Manufacturing Engineering and Automation, or Fraunhofer IPA for short, is one of the largest institutes in the Fraunhofer-Society, with almost 1,200 employees. The institute’s research focuses on organisational and technological tasks in production. Methods, components and devices through to complete machines and systems are developed, tested and realised. 19 specialised departments work together on an interdisciplinary basis, coordinated by 6 business units, primarily with the automotive, mechanical and plant engineering, electronics and microsystems technology, energy, medical and biotechnology and process industries. Fraunhofer IPA focuses its research on the economic production of sustainable and personalised products.
Contact for the media:
Q.ANT GmbH
Joerg Kochendoerfer
Fellow Marketing Manager
+49 160 5619730
joerg.kochendoerfer@qant.gmbh
www.qant.com
